Aberrant Behavior Checklist in Fragile X Syndrome

With a $10,000 FRAXA grant, Dr. David Hessl at UC Davis analyzed the Aberrant Behavior Checklist as a key outcome measure for Fragile X. Results were published.

Read More »

Melatonin Clinical Trial in Fragile X

FRAXA-funded Dr. Hagerman’s UC team explored melatonin’s effects in Fragile X, advancing understanding of treatment options. Results published.

Read More »
Paul Hagerman, PhD

FMR1 Gene Regulation

FRAXA-funded Dr. Paul Hagerman explored reactivating the FMR1 gene and measuring its expression to advance Fragile X treatment.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (42)